Navigation Links
Boston Scientific To Participate In LEERINK Partners 6th Annual Global Healthcare Conference
Date:2/1/2017

MARLBOROUGH, Mass., Feb. 1, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the LEERINK Partners 6th Annual Global Healthcare Conference on February 15, in New York.

Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer-session with the host analyst beginning at approximately 3:00pm.

A live webcast of the question-and-answer-session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors. We encourage interested parties to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTSMedia:            

Investors:Tom Keppeler                     

Susie Lisa, CFA508-683-6585 (office)               

508- 683-5565 (office)Media Relations                    

Investor RelationsBoston Scientific Corporation      

Boston Scientific Corporationthomas.keppeler@bsci.com             

investor_relations@bsci.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-leerink-partners-6th-annual-global-healthcare-conference-300399773.html


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
2. Boston Scientific Announces Collaboration with Pelvic Floor Disorders Network to Study Treatment Strategies for Uterine Prolapse
3. Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology
4. Approval Of Boston Scientifics Watchman Device Will Support Rapid Growth In The Global Heart Defect Closure Device Market
5. FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark
6. Boston Biomedical announces the Grand Opening of its Cambridge Headquarters
7. Abilities Expo--the Nations Leading Event for People with Disabilities--Makes Boston Debut September 20-22
8. Global Vascular Stents Market 2012-2016 Report with Abbott Laboratories, Medtronic Inc. and Boston Scientific Corp. Dominating
9. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
10. OrbusNeich, Boston Scientific Settle Patent Litigation
11. Boston Scientific Opens Institute For Advancing Science, Innovation Center In Shanghai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2019)... ... November 15, 2019 , ... JustCBD looks forward to working ... Warriors was founded by the military families aboard Marine Corps Base Camp Lejeune, ... and their families. For the past 13 years, Hope For The Warriors has been ...
(Date:11/14/2019)... TAUNTON, Mass. (PRWEB) , ... November 14, 2019 ... ... to offering innovative green, natural, clean, safe, and effective products to health and ... “Deodorant Product of the Year” award. , The award is presented by the ...
(Date:11/14/2019)... ... November 14, 2019 , ... ... the earliest stages of disease development or their recurrence, is attracting interest and ... Research Institute), now part of Nuvance Health, and the Icahn School of Medicine ...
Breaking Medicine Technology:
(Date:11/14/2019)... ... November 14, 2019 , ... EMulate Therapeutics, Inc., ... diseases, announced it will have 5 poster presentations related to its medical devices ... for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 . ...
(Date:11/14/2019)... ... 14, 2019 , ... AstraZeneca and MSD (Merck) announced today ... status of its application for the MEK inhibitor selumetinib, for use in patients ... The FDA’s acceptance of the application is a major milestone for selumetinib becoming ...
(Date:11/12/2019)... , ... November 12, 2019 , ... AI for preventable ... KLAS report “Healthcare AI 2019 - Actualizing the Potential of AI”, which provides ... leader and the only healthcare-focused AI company with enough clients to complete a full ...
(Date:11/12/2019)... , ... November 12, 2019 , ... ... clinical study. With increasing site activation cycle times, extended contract negotiations and 80 ... is an area of clinical operations that’s ripe for improvement. Following an overview ...
(Date:11/11/2019)... ... ... Early praise for A Nurse’s Step-by-Step Guide to Publishing a Dissertation or DNP Project: ... and vital guidance for publishing dissertations or DNP projects. A Nurse’s Step-by-Step Guide to ... and will be shared with new graduates and colleagues alike.” , -Nancy White ...
Breaking Medicine News(10 mins):